P2Y 6 Deficiency Limits Vascular Inflammation and Atherosclerosis in Mice

Autor: Dennis Wolf, Cemil Korcan Ayata, Timoteo Marchini, Nathaly Anto Michel, Natalie Hoppe, Lisa Schulte, Alexander Peikert, Sanja Cicko, Christoph Bode, Jochen Reinöhl, Constantin von zur Mühlen, Marco Idzko, Sonja Hergeth, Peter Stachon, Andreas Zirlik, Bianca Dufner, Melanie Grimm
Rok vydání: 2014
Předmět:
Chemokine
medicine.medical_specialty
CIENCIAS MÉDICAS Y DE LA SALUD
Time Factors
Aortic Diseases
VASCULAR CELL ADHESION MOLECULE-1
Inflammation
Medicina Clínica
Uridine Diphosphate
Proinflammatory cytokine
Cholesterol
Dietary

P2Y6 RECEPTOR
Mice
INFLAMMATION
Internal medicine
purl.org/becyt/ford/3.2 [https]
medicine
Animals
Leukocyte Rolling
URIDINE DIPHOSPHATE
Aorta
Bone Marrow Transplantation
Mice
Knockout

biology
Receptors
Purinergic P2

Cell adhesion molecule
Macrophages
Purinergic receptor
Transendothelial and Transepithelial Migration
RECEPTORS
PURINERGIC P2

Atherosclerosis
Plaque
Atherosclerotic

Disease Models
Animal

CXCL2
Endocrinology
ATHEROSCLEROSIS
Receptors
LDL

CXCL5
Immunology
biology.protein
purl.org/becyt/ford/3 [https]
Medicina Critica y de Emergencia
Inflammation Mediators
medicine.symptom
Cardiology and Cardiovascular Medicine
Signal Transduction
Lipoprotein
Zdroj: CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
ISSN: 1524-4636
1079-5642
Popis: Objective— Nucleotides such as ATP, ADP, UTP, and UDP serve as proinflammatory danger signals via purinergic receptors on their release to the extracellular space by activated or dying cells. UDP binds to the purinergic receptor Y 6 (P2Y 6 ) and propagates vascular inflammation by inducing the expression of chemokines such as monocyte chemoattractant protein 1, interleukin-8, or its mouse homologsCCL1 (chemokine [C-C motif] ligand 1)/keratinocyte chemokine, CXCL2 (chemokine [C-X-C motif] ligand 2)/macrophage inflammatory protein 2, and CXCL5 (chemokine [C-X-C motif] ligand 5)/LIX, and adhesion molecules such as vascular cell adhesion molecule 1 and intercellular cell adhesion molecule 1. Thus, P2Y 6 contributes to leukocyte recruitment and inflammation in conditions such as allergic asthma or sepsis. Because atherosclerosis is a chronic inflammatory disease driven by leukocyte recruitment to the vessel wall, we hypothesized a role of P2Y 6 in atherogenesis. Approach and Results— Intraperitoneal stimulation of wild-type mice with UDP induced rolling and adhesion of leukocytes to the vessel wall as assessed by intravital microscopy. This effect was not present in P2Y 6 -deficient mice. Atherosclerotic aortas of low-density lipoprotein receptor–deficient mice consuming high-cholesterol diet for 16 weeks expressed significantly more transcripts and protein of P2Y 6 than respective controls. Finally, P2Y 6 −/− /low-density lipoprotein receptor–deficient mice consuming high-cholesterol diet for 16 weeks developed significantly smaller atherosclerotic lesions compared with P2Y 6 +/+ /low-density lipoprotein receptor–deficient mice. Bone marrow transplantation identified a crucial role of P2Y 6 on vascular resident cells, most likely endothelial cells, on leukocyte recruitment and atherogenesis. Atherosclerotic lesions of P2Y 6 -deficient mice contained fewer macrophages and fewer lipids as determined by immunohistochemistry. Mechanistically, RNA expression of vascular cell adhesion molecule 1 and interleukin-6 was decreased in these lesions and P2Y 6 -deficient macrophages took up less modified low-density lipoprotein cholesterol. Conclusions— We show for the first time that P2Y 6 deficiency limits atherosclerosis and plaque inflammation in mice.
Databáze: OpenAIRE